1. Home
  2. RDHL vs MFI Comparison

RDHL vs MFI Comparison

Compare RDHL & MFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • MFI
  • Stock Information
  • Founded
  • RDHL 2009
  • MFI 2002
  • Country
  • RDHL Israel
  • MFI Hong Kong
  • Employees
  • RDHL N/A
  • MFI N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • MFI
  • Sector
  • RDHL Health Care
  • MFI
  • Exchange
  • RDHL Nasdaq
  • MFI NYSE
  • Market Cap
  • RDHL 3.8M
  • MFI 8.2M
  • IPO Year
  • RDHL N/A
  • MFI 2024
  • Fundamental
  • Price
  • RDHL $2.00
  • MFI $5.89
  • Analyst Decision
  • RDHL
  • MFI
  • Analyst Count
  • RDHL 0
  • MFI 0
  • Target Price
  • RDHL N/A
  • MFI N/A
  • AVG Volume (30 Days)
  • RDHL 20.0K
  • MFI 2.0M
  • Earning Date
  • RDHL 04-10-2025
  • MFI 04-23-2025
  • Dividend Yield
  • RDHL N/A
  • MFI N/A
  • EPS Growth
  • RDHL N/A
  • MFI N/A
  • EPS
  • RDHL N/A
  • MFI N/A
  • Revenue
  • RDHL $8,042,999.00
  • MFI $3,358,264.00
  • Revenue This Year
  • RDHL $381.91
  • MFI N/A
  • Revenue Next Year
  • RDHL N/A
  • MFI N/A
  • P/E Ratio
  • RDHL N/A
  • MFI N/A
  • Revenue Growth
  • RDHL 23.17
  • MFI N/A
  • 52 Week Low
  • RDHL $1.71
  • MFI $0.51
  • 52 Week High
  • RDHL $20.28
  • MFI $6.95
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 55.20
  • MFI N/A
  • Support Level
  • RDHL $1.75
  • MFI N/A
  • Resistance Level
  • RDHL $2.08
  • MFI N/A
  • Average True Range (ATR)
  • RDHL 0.10
  • MFI 0.00
  • MACD
  • RDHL 0.02
  • MFI 0.00
  • Stochastic Oscillator
  • RDHL 76.92
  • MFI 0.00

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via the internet or a platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

Share on Social Networks: